ELICIO THERAPEUTICS, INC. PRE-FUNDED WARRANT TO PURCHASE COMMON STOCKElicio Therapeutics, Inc. • July 1st, 2024 • Pharmaceutical preparations
Elicio Therapeutics, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, __________ (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company up to a total of ___ shares of common stock, $0.01 par value per share (the “Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price per share equal to $0.01 per share (as adjusted from time to time as provided in Section 9 herein, the “Exercise Price”), upon surrender of this Pre-Funded Warrant to Purchase Common Stock (the “Warrant” (which, for the avoidance of doubt, shall include any New Warrant (as defined below))) at any time and from time to time on or after the date hereof (the “Original Issue Date”), subject to the following terms and conditions:
ELICIO THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCKElicio Therapeutics, Inc. • July 1st, 2024 • Pharmaceutical preparations • New York
Elicio Therapeutics, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [ ● ], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon surrender of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this “Warrant”), at any time or times on or after [ ● ] (the “Issuance Date”), but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), _____________________ fully paid non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set forth in Section 16.
ELICIO THERAPEUTICS, INC. 500,000 SHARES OF COMMON STOCK (PAR VALUE $0.01) WARRANTS TO PURCHASE 2,300,000 SHARES OF COMMON STOCK PRE-FUNDED WARRANTS TO PURCHASE 1,800,000 SHARES OF COMMON STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • July 1st, 2024 • Elicio Therapeutics, Inc. • Pharmaceutical preparations • New York
